Bibliography
- Nathan C. Points of control in inflammation. Nature 2002;420:846-52
- Hasko G, Linden J, Cronstein B, Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov 2008;7:759-70
- Antonioli L, Fornai M, Colucci R, Regulation of enteric functions by adenosine: pathophysiological and pharmacological implications. Pharmacol Ther 2008;120:233-53
- Hasko G, Cronstein BN. Adenosine: an endogenous regulator of innate immunity. Trends Immunol 2004;25:33-9
- Hasko G, Pacher P, Deitch EA, Shaping of monocyte and macrophage function by adenosine receptors. Pharmacol Ther 2007;113:264-75
- Volonte C, D'Ambrosi N. Membrane compartments and purinergic signalling: the purinome, a complex interplay among ligands, degrading enzymes, receptors and transporters. FEBS J 2009;276:318-29
- Koscso B, Csoka B, Pacher P, Hasko G. Investigational A(3) adenosine receptor targeting agents. Expert Opin Investig Drugs 2011; in press
- Linden J. Cell biology. Purinergic chemotaxis. Science 2006;314:1689-90
- Theron AJ, Steel HC, Tintinger GR, Endogenous adenosine regulates neutrophil pro-inflammatory activities by cyclic AMP-dependent accelerated clearance of cytosolic calcium. Inflamm Res 2002;51:594-602
- Sun WC, Moore JN, Hurley DJ, Effects of stimulation of adenosine A2A receptors on lipopolysaccharide-induced production of reactive oxygen species by equine neutrophils. Am J Vet Res 2007;68:649-56
- Thiele A, Kronstein R, Wetzel A, Regulation of adenosine receptor subtypes during cultivation of human monocytes: role of receptors in preventing lipopolysaccharide-triggered respiratory burst. Infect Immun 2004;72:1349-57
- Nemeth ZH, Lutz CS, Csoka B, Adenosine augments IL-10 production by macrophages through an A2B receptor-mediated posttranscriptional mechanism. J Immunol 2005;175:8260-70
- Schnurr M, Toy T, Shin A, Role of adenosine receptors in regulating chemotaxis and cytokine production of plasmacytoid dendritic cells. Blood 2004;103:1391-7
- Dickenson JM, Reeder S, Rees B, Functional expression of adenosine A2A and A3 receptors in the mouse dendritic cell line XS-106. Eur J Pharmacol 2003;474:43-51
- Koshiba M, Rosin DL, Hayashi N, Patterns of A2A extracellular adenosine receptor expression in different functional subsets of human peripheral T cells. Flow cytometry studies with anti-A2A receptor monoclonal antibodies. Mol Pharmacol 1999;55:614-24
- Gessi S, Varani K, Merighi S, Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation. Mol Pharmacol 2004;65:711-19
- Gessi S, Merighi S, Varani K, The A3 adenosine receptor: an enigmatic player in cell biology. Pharmacol Ther 2008;117:123-40
- Press NJ, Fozard JR. Progress towards novel adenosine receptor therapeutics gleaned from the recent patent literature. Expert Opin Ther Pat 2010;20:987-1005
- Gessi S, Cattabriga E, Avitabile A, Elevated expression of A3 adenosine receptors in human colorectal cancer is reflected in peripheral blood cells. Clin Cancer Res 2004;10:5895-901
- Gessi S, Merighi S, Sacchetto V, Adenosine receptors and cancer. Biochim Biophys Acta 2011;1808:1400-12
- Hasko G, Pacher P. A2A receptors in inflammation and injury: lessons learned from transgenic animals. J Leukoc Biol 2008;83:447-55
- Fredholm BB, Ijzerman AP, Jacobson KA, International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update. Pharmacol Rev 2011;63:1-34
- Antonioli L, Fornai M, Colucci R, Inhibition of adenosine deaminase attenuates inflammation in experimental colitis. J Pharmacol Exp Ther 2007;322:435-42
- Antonioli L, Fornai M, Colucci R, The blockade of adenosine deaminase ameliorates chronic experimental colitis through the recruitment of adenosine A2A and A3 receptors. J Pharmacol Exp Ther 2010;335:434-42
- Drew BG, Kingwell BA. Acadesine, an adenosine-regulating agent with the potential for widespread indications. Expert Opin Pharmacother 2008;9:2137-44